پنجشنبه 28 فروردین 1404
[Archive]
دوره 19، شماره 5 - ( 3-1400 )
جلد 19 شماره 5 صفحات 41-41 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nikukar H. K-41 Regenerative medicine for female reproductive system. IJRM 2021; 19 (5) :41-41
URL: http://ijrm.ir/article-1-2771-fa.html
URL: http://ijrm.ir/article-1-2771-fa.html
K-41 Regenerative medicine for female reproductive system. International Journal of Reproductive BioMedicine. 1400; 19 (5) :41-41
چکیده: (190 مشاهده)
Tissue engineering and regenerative medicine make a bright future for the regeneration, repair, and replacement of various tissues and organs. In the reproductive system, most of the major acquired or congenital organ failures lead to a great functional problem, infertility. Everybody with infertility will have great social and family obstacles, often with psychological consequences for the couples.
Regenerating the absent organ or repairing and replacing the diseased tissue are the novel choices for the treatment of reproductive system diseases due to organ or tissue failure. By tissue engineering for female patients, that is using the triad of potent cells, scaffolds and growth factors could make an artificial uterus, tubal organs, ovary, and follicles. Selection of the best cells, scaffolds, and stimulation factors to make a functional tissue is the aim of many research programs around the world. Various types of stem cells, organic and inorganic biocompatible scaffolds, and different types of proteins, enzymes, and small molecules as stimulators have been used. Engineered tissues could apply as the in vitro research models and for clinical use to restore reproductive function.
Taken together, this medical technology prepares the introductory facilities for germ cell support and in vitro fetal growth and complete artificial uterus for ex vivo embryo growth and maturation (biobag). For all the possible instances, religious beliefs, law and reproductive health ethics should be considered.
Regenerating the absent organ or repairing and replacing the diseased tissue are the novel choices for the treatment of reproductive system diseases due to organ or tissue failure. By tissue engineering for female patients, that is using the triad of potent cells, scaffolds and growth factors could make an artificial uterus, tubal organs, ovary, and follicles. Selection of the best cells, scaffolds, and stimulation factors to make a functional tissue is the aim of many research programs around the world. Various types of stem cells, organic and inorganic biocompatible scaffolds, and different types of proteins, enzymes, and small molecules as stimulators have been used. Engineered tissues could apply as the in vitro research models and for clinical use to restore reproductive function.
Taken together, this medical technology prepares the introductory facilities for germ cell support and in vitro fetal growth and complete artificial uterus for ex vivo embryo growth and maturation (biobag). For all the possible instances, religious beliefs, law and reproductive health ethics should be considered.
نوع مطالعه: Congress Abstract |
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
